Charlotte Retention in Care Study

Completed

• Conditions: HIV I Infection
• Interventions: Other: Alert to provider

• Registration Number: NCT03584048
• Lead Sponsor: Epividian

Brief Summary

The objective of the Charlotte Retention in Care study is to assess if clinical decision support systems (CDSS) that produce standardized alerts for measures of retention in care across clinics in the city of Charlotte, North Carolina have the ability to increase retention in care measures within clinics and in surveillance reports.

Detailed Description

Multiple Charlotte HIV Clinic providers are participating. "Primary" HIV provider will be defined as the primary physician or advanced care practitioner following a patient, as recorded in their respective Electronic Health Record (EHR) system and identified through CHORUS, a Clinical Decision Support System (CDSS) developed by Epividian. The CDSS will track patient case status as active or inactive (loss to follow-up, transferred medical care, or deceased). Providers will be informed of the study and sites will be contracted to participate in this collaborative research study. This study was approved by the Advarra Institutional Review Board.

Study Timeline

• Study First Submitted: 2018-05-17
• Study Start: 2018-07-01
• Study First Submitted QC: 2018-07-10
• Study First Posted: 2018-07-12
• Status Verified: 2019-10
• Primary Completion: 2019-10-31
• Study Completion: 2019-10-31
• Last Update Submitted: 2021-10-27
• Last Update Posted: 2021-11-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 6500

Inclusion Criteria

• HIV-1+
• Any gender
• 18 years old or older
• Residing in the Charlotte, North Carolina metropolitan area
• At least a single entry in the EHR in the last 2 years

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
HIV-1	Alert to provider	HIV-1+, males, females, transgender, ≥18 years of age, residing in the Charlotte Metropolitan Area and with at least a single entry in the EHR in the last 2 years.

Primary Outcome Measures

Name	Time	Method
Engagement level	12 months, 01-Nov-2018 to 31-Oct-2019	Pre and post-baseline engagement level. Engagement level is defined as patients with 0, 1, or 2+ visits to physician (identified as a visit that included the collection of 1 viral load and/or 1 CD4 count lab test).

Secondary Outcome Measures

Name	Time	Method
Kept appointment	12 months, 01-Nov-2018 to 31-Oct-2019	Pre and post-baseline "kept appointment rate", the proportion of patients who attended their scheduled office visits.

Trial Locations

Locations (4)

Amity Group Foundation; 🇺🇸 Charlotte, North Carolina, United States

Ballantyne Family Medicine; 🇺🇸 Charlotte, North Carolina, United States

Rosedale Medical; 🇺🇸 Huntersville, North Carolina, United States

Atrium Health; 🇺🇸 Charlotte, North Carolina, United States